{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:49:54Z","timestamp":1792698594973,"version":"4.5.0"},"reference-count":175,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.msard.2025.106667","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T02:46:33Z","timestamp":1754621193000},"page":"106667","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Prediction of long-term outcome in Multiple Sclerosis: A systematic review"],"prefix":"10.1016","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2718-1828","authenticated-orcid":false,"given":"Saloua","family":"Mrabet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Conesa","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Giovannoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2025.106667_bib0001","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-020-10093-1","article-title":"Parity and disability progression in relapsing\u2013remitting multiple sclerosis","author":"Achiron","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-510X(99)00143-4","article-title":"A prospective study on the natural history of multiple sclerosis: clues to the conduct and interpretation of clinical trials","author":"Amato","year":"1999","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2025.106667_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2014.11.008","article-title":"Place of birth, age of immigration, and disability in Hispanics with multiple sclerosis","author":"Amezcua","year":"2015","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106667_bib0004","doi-asserted-by":"crossref","DOI":"10.1177\/13524585211057767","article-title":"Pregnancy in women with MS: impact on long-term disability accrual in a nationwide Danish cohort","author":"Andersen","year":"2022","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106667_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2019.109310","article-title":"Clinical and diagnostic features of patients with familial multiple sclerosis","author":"Andrijauskis","year":"2019","journal-title":"Med. Hypotheses."},{"key":"10.1016\/j.msard.2025.106667_bib0006","doi-asserted-by":"crossref","DOI":"10.1177\/1352458508099479","article-title":"Gender-related differences in MS: a study of conventional and nonconventional MRI measures","author":"Antulov","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106667_bib0007","doi-asserted-by":"crossref","DOI":"10.1586\/14737175.2013.865866","article-title":"Environmental factors in multiple sclerosis","author":"Ascherio","year":"2013","journal-title":"Expert. Rev. NeurOther"},{"key":"10.1016\/j.msard.2025.106667_bib0008","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2013.5993","article-title":"Vitamin D as an early predictor of multiple sclerosis activity and progression","author":"Ascherio","year":"2014","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0009","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2014.79","article-title":"Inadequacy of clinical trial designs and data to control for the confounding impact of race\/ethnicity in response to treatment in multiple sclerosis","author":"Avasarala","year":"2014","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0010","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.medici.2016.07.004","article-title":"Associations of HLA DRB1 alleles with IgG oligoclonal bands and their influence on multiple sclerosis course and disability status","volume":"52","author":"Balnyt\u0117","year":"2016","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.msard.2025.106667_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103115","article-title":"Early predictors of conversion to secondary progressive multiple sclerosis","author":"Barzegar","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106667_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103115","article-title":"Early predictors of conversion to secondary progressive multiple sclerosis","author":"Barzegar","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106667_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-510X(01)00572-X","article-title":"Predicting secondary progression in relapsing-remitting multiple sclerosis: a Bayesian analysis","author":"Bergamaschi","year":"2001","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2025.106667_bib0014","doi-asserted-by":"crossref","DOI":"10.1111\/ane.12429","article-title":"Socio-economic factors and immigrant population studies of multiple sclerosis","author":"Berg-Hansen","year":"2015","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.msard.2025.106667_bib0015","doi-asserted-by":"crossref","DOI":"10.1111\/ene.12227","article-title":"Increased disease severity in non-Western immigrants with multiple sclerosis in Oslo, Norway","author":"Berg-Hansen","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0016","doi-asserted-by":"crossref","DOI":"10.1177\/1352458509360549","article-title":"Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study","author":"Bermel","year":"2010","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106667_bib0017","doi-asserted-by":"crossref","DOI":"10.1177\/1352458518782005","article-title":"Neurofilaments and 10-year follow-up in multiple sclerosis","author":"Bhan","year":"2018","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106667_bib0018","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp.2009.201574","article-title":"T2 lesion location really matters: a 10-year follow-up study in primary progressive multiple sclerosis","author":"Bodini","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2025.106667_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102885","article-title":"MS and disability progression in Latin America, Africa, Asia and the Middle East: a systematic review","author":"Bonomi","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106667_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.01.045","article-title":"Prognostic factors of disability in relapsing remitting multiple sclerosis","author":"Briggs","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106667_bib0021","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awz156","article-title":"Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis","author":"Brownlee","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.msard.2025.106667_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158978","article-title":"Long term clinical prognostic factors in relapsing-remitting multiple sclerosis: insights from a 10-year observational study","author":"Bsteh","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.msard.2025.106667_bib0023","doi-asserted-by":"crossref","DOI":"10.1177\/1352458517740216","article-title":"Peripapillary retinal nerve fibre layer as measured by optical coherence tomography is a prognostic biomarker not only for physical but also for cognitive disability progression in multiple sclerosis","author":"Bsteh","year":"2019","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106667_bib0024","article-title":"Long-term evolution of multiple sclerosis disability in the treatment era","author":"California","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0025","article-title":"Silent progression in disease activity-free relapsing multiple sclerosis","author":"California","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.827738","article-title":"High levels of cerebrospinal fluid Kappa free light chains relate to IgM intrathecal synthesis and might have prognostic implications in relapsing multiple sclerosis","author":"Castillo-Villalba","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2025.106667_bib0028","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s41512-021-00106-6","article-title":"Development, validation and clinical usefulness of a prognostic model for relapse in relapsing-remitting multiple sclerosis","volume":"5","author":"Chalkou","year":"2021","journal-title":"Diagnostic Progn. Res."},{"key":"10.1016\/j.msard.2025.106667_bib0029","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.56.3.312","article-title":"APOE genotype is a major predictor of long-term progression of disability in MS","author":"Chapman","year":"2001","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2025.106667_bib0030","doi-asserted-by":"crossref","DOI":"10.1002\/ana.25637","article-title":"A 30-year clinical and Magnetic resonance imaging observational study of multiple sclerosis and clinically isolated syndromes","author":"Chung","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102565","article-title":"Prevalence of comorbidities in Multiple Sclerosis and impact on physical disability according to disease phenotypes","author":"Ciampi","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106667_bib0032","doi-asserted-by":"crossref","DOI":"10.1159\/000110190","article-title":"Multiple sclerosis: disability and mortality in a cohort of clinically diagnosed patients","author":"Citterio","year":"1989","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.msard.2025.106667_bib0033","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awg081","article-title":"Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process","author":"Confavreux","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.msard.2025.106667_bib0034","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM200011163432001","article-title":"Relapses and progression of disability in multiple sclerosis","author":"Confavreux","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2025.106667_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2015.03.006","article-title":"Smoking worsens multiple sclerosis prognosis: two different pathways are involved","author":"Correale","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2025.106667_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.jval.2022.03.010","article-title":"Multiple sclerosis progressive courses: a clinical cohort long-term disability progression study","author":"Cortesi","year":"2022","journal-title":"Value Health"},{"key":"10.1016\/j.msard.2025.106667_bib0037","article-title":"The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis","author":"Cottrell","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.msard.2025.106667_bib0038","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1212\/WNL.64.12.2163","article-title":"Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis [2]","volume":"64","author":"Cree","year":"2005","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2025.106667_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.nrl.2014.12.015","article-title":"Esclerosis m\u00faltiple y embarazo : estudio unic\u00e9ntrico prospectivo y comparativo","author":"Cuello","year":"2017","journal-title":"Neurologia (Engl. Ed)"},{"key":"10.1016\/j.msard.2025.106667_bib0040","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp.2008.163816","article-title":"Long-term effects of childbirth in MS","author":"D\u2019Hooghe","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2025.106667_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2012.09.020","article-title":"Prognostic indicators for long-term disability in multiple sclerosis patients","author":"Damasceno","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2025.106667_bib0042","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17020234","article-title":"Offspring number does not influence reaching the disability's milestones in multiple sclerosis: a seven-year follow-up study","author":"D'Amico","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2025.106667_bib0043","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000350","article-title":"Gene variants of adhesion molecules act as modifiers of disease severity in MS","author":"Dardiotis","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2025.106667_bib0044","article-title":"Late onset multiple sclerosis: concerns in aging patients","author":"De Campos Lotti","year":"2017","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.msard.2025.106667_bib0045","doi-asserted-by":"crossref","DOI":"10.1111\/j.1468-1331.2008.02241.x","article-title":"Natural history of multiple sclerosis in a population-based cohort","author":"Debouverie","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0046","doi-asserted-by":"crossref","DOI":"10.1038\/nrneurol.2009.178","article-title":"Clinical prognostic factors in multiple sclerosis: a natural history review","author":"Degenhardt","year":"2009","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0047","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193407","article-title":"Do people with multiple sclerosis want to know their prognosis? A UK nationwide study","author":"Dennison","year":"2018","journal-title":"PLoS. One"},{"key":"10.1016\/j.msard.2025.106667_bib0048","doi-asserted-by":"crossref","DOI":"10.3399\/bjgp14X682609","article-title":"Editorials: what\u2019s new in multiple sclerosis?","author":"Dimitrov","year":"2014","journal-title":"Br. J. Gen. Pract."},{"key":"10.1016\/j.msard.2025.106667_bib0049","doi-asserted-by":"crossref","DOI":"10.1111\/ene.13819","article-title":"Multiple sclerosis \u2013 a review","author":"Dobson","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0050","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2012-304695","article-title":"Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude","author":"Dobson","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2025.106667_bib0051","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/123.3.641","article-title":"The natural history of multiple sclerosis: a geographically based study. 8. Familial multiple sclerosis","author":"Ebers","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.msard.2025.106667_bib0053","first-page":"44","article-title":"Prognostic factors in multiple sclerosis","volume":"2","author":"Espiritu","year":"2022","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0054","doi-asserted-by":"crossref","DOI":"10.3390\/neurolint13030034","article-title":"Cognitive dysfunction in multiple sclerosis: educational level as a protective factor","author":"Estrada-L\u00f3pez","year":"2021","journal-title":"Neurol. Int."},{"key":"10.1016\/j.msard.2025.106667_bib0055","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/1352458519868990","article-title":"Risk of secondary progressive multiple sclerosis: a longitudinal study","volume":"26","author":"Fambiatos","year":"2020","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2025.106667_bib0056","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awm329","article-title":"Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis","author":"Fisniku","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.msard.2025.106667_bib0057","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ana.21423","article-title":"Gray matter atrophy is related to long-term disability in multiple sclerosis","volume":"64","author":"Fisniku","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0058","doi-asserted-by":"crossref","DOI":"10.1177\/1352458509358088","article-title":"Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate","author":"Ford","year":"2010","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106667_bib0059","doi-asserted-by":"crossref","DOI":"10.1191\/135248506ms1318oa","article-title":"A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patients","author":"Ford","year":"2006","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106667_bib0060","doi-asserted-by":"crossref","DOI":"10.1038\/nrneurol.2012.200","article-title":"Neuroprotection and repair in multiple sclerosis","author":"Franklin","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0061","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2019.0905","article-title":"Association of intrathecal immunoglobulin G synthesis with disability worsening in multiple sclerosis","author":"Gasperi","year":"2019","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0062","doi-asserted-by":"crossref","DOI":"10.1007\/s13760-016-0650-1","article-title":"Do evoked potentials contribute to the functional follow-up and clinical prognosis of multiple sclerosis?","author":"Giffroy","year":"2017","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.msard.2025.106667_bib0063","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2015.09.002","article-title":"Relapses in multiple sclerosis: relationship to disability","author":"Goodin","year":"2016","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106667_bib0064","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000012362","article-title":"Association of Disease Severity and Socioeconomic Status in black and white Americans with multiple sclerosis","author":"Gray Roncal","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106667_bib0065","doi-asserted-by":"crossref","DOI":"10.1212\/CON.0000000000000738","article-title":"Monitoring, switching, and stopping multiple sclerosis disease-modifying therapies","author":"Gross","year":"2019","journal-title":"Contin. Lifelong Learn. Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0066","doi-asserted-by":"crossref","DOI":"10.1159\/000479516","article-title":"Older age at multiple sclerosis onset is an independent factor of poor prognosis: a population-based cohort study","author":"Guillemin","year":"2017","journal-title":"Neuroepidemiology."},{"key":"10.1016\/j.msard.2025.106667_bib0067","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2018.4905","article-title":"Clinical outcomes of escalation vs early intensive disease-modifying therapy in patients with multiple sclerosis","author":"Harding","year":"2019","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0068","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000007190","article-title":"Socioeconomic status and disability progression in multiple sclerosis: a multinational study","author":"Harding","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106667_bib0069","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000856","article-title":"Long-term prognostic value of longitudinal measurements of blood neurofilament levels","author":"H\u00e4ring","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2025.106667_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2020.05.049","article-title":"Treatment of Multiple sclerosis","author":"Hauser","year":"2020","journal-title":"Am. J. Med."},{"key":"10.1016\/j.msard.2025.106667_bib0071","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0b013e3181ed9c9c","article-title":"HLA B*44: protective effects in MS susceptibility and MRI outcome measures","author":"Healy","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106667_bib0072","doi-asserted-by":"crossref","DOI":"10.1002\/hbm.21334","article-title":"Human brain changes across the life span: a review of 56 longitudinal magnetic resonance imaging studies","author":"Hedman","year":"2012","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.msard.2025.106667_bib0073","doi-asserted-by":"crossref","DOI":"10.1212\/01.wnl.0000252822.53506.46","article-title":"Familial effects on the clinical course of multiple sclerosis","author":"Hensiek","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106667_bib0074","doi-asserted-by":"crossref","DOI":"10.1111\/ane.12916","article-title":"Smoking and worsening disability in multiple sclerosis: a meta-analysis","author":"Heydarpour","year":"2018","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.msard.2025.106667_bib0075","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2018.2109","article-title":"Association of inflammation and disability accrual in patients with progressive-onset multiple sclerosis","author":"Hughes","year":"2018","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0076","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2009.03.005","article-title":"HLA-DRB1\u00d715 and cerebrospinal-fluid-specific oligoclonal immunoglobulin G bands lower age at attainment of important disease milestones in multiple sclerosis","author":"Imrell","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2025.106667_bib0077","article-title":"Locus for severity implicates CNS resilience in progression of multiple sclerosis","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.msard.2025.106667_bib0079","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2020.1568","article-title":"Contribution of relapse-independent progression vs relapse-associated worsening to overall confirmed disability accumulation in typical relapsing multiple sclerosis in a pooled analysis of 2 randomized clinical trials","author":"Kappos","year":"2020","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2018.08.021","article-title":"Familial multiple sclerosis in Greece: distinct clinical and imaging characteristics in comparison with the sporadic disease","author":"Katsavos","year":"2018","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.msard.2025.106667_bib0081","doi-asserted-by":"crossref","DOI":"10.1177\/1352458516675039","article-title":"Importance of early treatment initiation in the clinical course of multiple sclerosis","author":"Kavaliunas","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106667_bib0082","doi-asserted-by":"crossref","DOI":"10.1002\/ana.21375","article-title":"Predicting progression in primary progressive multiple sclerosis: a 10-year multicenter study","author":"Khaleeli","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0083","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0b013e3181e8e72a","article-title":"Rapid disease course in African Americans with multiple sclerosis","author":"Kister","year":"2010","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2025.106667_bib0084","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028928","article-title":"Clinical course of Multiple sclerosis","author":"Klineova","year":"2018","journal-title":"Cold. Spring. Harb. Perspect. Med."},{"key":"10.1016\/j.msard.2025.106667_bib0085","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2017.0377","article-title":"Association of retinal architecture, intrathecal immunity, and clinical course in Multiple Sclerosis","author":"Knier","year":"2017","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0087","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awh721","article-title":"The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease","author":"Kremenchutzky","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.msard.2025.106667_bib0088","doi-asserted-by":"crossref","DOI":"10.1001\/archneur.63.12.1686","article-title":"Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: a systematic review","author":"Langer-Gould","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0089","doi-asserted-by":"crossref","DOI":"10.1007\/BF00862981","article-title":"Prognostic criteria in an epidemiological group of patients with multiple sclerosis: an exploratory study","author":"Lauer","year":"1992","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0090","doi-asserted-by":"crossref","DOI":"10.1177\/1352458520926955","article-title":"Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis","author":"Le","year":"2021","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2025.106667_bib0091","doi-asserted-by":"crossref","DOI":"10.1177\/135245859900500306","article-title":"Prognostic factors for survival in multiple sclerosis","author":"Levi\u0107","year":"1999","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106667_bib0092","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinph.2016.12.029","article-title":"Early disturbances in multimodal evoked potentials as a prognostic factor for long-term disability in relapsing-remitting multiple sclerosis patients","author":"London","year":"2017","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.msard.2025.106667_bib0093","doi-asserted-by":"crossref","DOI":"10.1007\/s40120-021-00297-6","article-title":"Effects of pregnancy and breastfeeding on clinical outcomes and MRI measurements of women with multiple sclerosis: an exploratory real-world cohort study","author":"Lorefice","year":"2022","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.msard.2025.106667_bib0094","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awac016","article-title":"How patients with multiple sclerosis acquire disability","author":"Lublin","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.msard.2025.106667_bib0095","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-018-1818-y","article-title":"Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis","author":"Luchetti","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.msard.2025.106667_bib0096","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awaa081","article-title":"Early clinical markers of aggressive multiple sclerosis","author":"Malpas","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.msard.2025.106667_bib0097","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-008-0827-5","article-title":"A multifactorial prognostic index in multiple sclerosis: cerebrospinal fluid IgM oligoclonal bands and clinical features to predict the evolution of the disease","author":"Mandrioli","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0098","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2018.00232","article-title":"Association of pre-disease body mass index with multiple sclerosis prognosis","author":"Manouchehrinia","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0099","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awt139","article-title":"Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study","author":"Manouchehriniufh na","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.msard.2025.106667_bib0100","doi-asserted-by":"crossref","DOI":"10.1177\/13524585211061861","article-title":"Body mass index as a predictor of MS activity and progression among participants in BENEFIT","author":"Manuel Escobar","year":"2022","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2025.106667_bib0101","doi-asserted-by":"crossref","DOI":"10.1007\/s10072-020-04727-5","article-title":"The prevalence of comorbidities in patients with multiple sclerosis: population-based registry data","author":"Maric","year":"2021","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.msard.2025.106667_bib0102","doi-asserted-by":"crossref","DOI":"10.1016\/j.ncl.2010.12.004","article-title":"Demographic, genetic, and environmental factors that modify disease course","author":"Marrie","year":"2011","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.msard.2025.106667_bib0103","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0b013e3181d6b125","article-title":"Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis","author":"Marrie","year":"2010","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2025.106667_bib0104","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(16)00068-5","article-title":"Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study","author":"Martinez-Lapiscina","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0105","doi-asserted-by":"crossref","DOI":"10.1177\/1352458514561907","article-title":"Parity is associated with a longer time to reach irreversible disability milestones in women with multiple sclerosis","author":"Masera","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106667_bib0106","article-title":"Menarche, oral contraceptives, pregnancy and progression of disability in relapsing onset and progressive onset multiple sclerosis","author":"MB","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0107","article-title":"Self-reported levels of education and disability progression in multiple sclerosis","author":"MB","year":"2016","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.msard.2025.106667_bib0108","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000005302","article-title":"Psychiatric comorbidity is associated with disability progression in multiple sclerosis","author":"McKay","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106667_bib0109","doi-asserted-by":"crossref","DOI":"10.1001\/archneur.61.2.217","article-title":"Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis","author":"Minneboo","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0110","doi-asserted-by":"crossref","DOI":"10.1177\/1352458509102617","article-title":"Association between MRI parameters and the MS severity scale: a 12-year follow-up study","author":"Minneboo","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106667_bib0111","doi-asserted-by":"crossref","DOI":"10.1177\/1352458515599075","article-title":"Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression","author":"Moccia","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106667_bib0112","doi-asserted-by":"crossref","DOI":"10.1111\/ene.13183","article-title":"Grey: white matter ratio at diagnosis and the risk of 10-year multiple sclerosis progression","author":"Moccia","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0113","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2023.0010","article-title":"Association of serum neurofilament light chain levels at disease onset with disability worsening in patients with a first demyelinating multiple sclerosis event not treated with high-efficacy drugs","author":"Monreal","year":"2023","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156122","article-title":"Vitamin D status does not affect disability progression of patients with multiple sclerosis over three year follow-up","author":"Muris","year":"2016","journal-title":"PLoS. One"},{"key":"10.1016\/j.msard.2025.106667_bib0115","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2018.00238","article-title":"Interplay between age and neuroinflammation in multiple sclerosis: effects on motor and cognitive functions","author":"Musella","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.msard.2025.106667_bib0116","doi-asserted-by":"crossref","DOI":"10.1177\/135245850100700110","article-title":"Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension","author":"Myhr","year":"2001","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106667_bib0117","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102816","article-title":"Clinical features of late-onset multiple sclerosis: a systematic review and meta-analysis","author":"Naseri","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106667_bib0118","doi-asserted-by":"crossref","DOI":"10.1177\/1352458519884006","article-title":"Remyelination and ageing: reversing the ravages of time","author":"Neumann","year":"2019","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2025.106667_bib0119","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000001856","article-title":"Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis","author":"Novotna","year":"2015","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2025.106667_bib0120","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awn301","article-title":"Genotype-phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures","author":"Okuda","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.msard.2025.106667_bib0121","series-title":"Prisma. Transparent Reporting of Systematic Reviews and Meta-Analyses","year":"2021"},{"key":"10.1016\/j.msard.2025.106667_bib0122","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.arcmed.2017.03.002","article-title":"Cigarette smoking, alcohol consumption and overweight in multiple sclerosis: disability progression","volume":"48","author":"Paz-Ballesteros","year":"2017","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.msard.2025.106667_bib0123","doi-asserted-by":"crossref","DOI":"10.1111\/jon.12788","article-title":"Assessment of racial\/ethnic disparities in volumetric MRI correlates of clinical disability in multiple sclerosis: a preliminary study","author":"P\u00e9rez","year":"2021","journal-title":"J. Neuroimaging"},{"key":"10.1016\/j.msard.2025.106667_bib0124","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.57.1.158","article-title":"The HLA-DR13 haplotype is associated with \u201cbenign\u201d multiple sclerosis in northeast Italy","author":"Perini","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106667_bib0125","doi-asserted-by":"crossref","DOI":"10.1111\/ene.14608","article-title":"The Framingham cardiovascular risk score and 5-year progression of multiple sclerosis","author":"Petruzzo","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0126","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/113.6.1597","article-title":"Clinical aspects of multiple sclerosis in North-East Scotland with particular reference to its course and prognosis","author":"Phadke","year":"1990","journal-title":"Brain"},{"key":"10.1016\/j.msard.2025.106667_bib0127","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinph.2019.11.024","article-title":"Upper limb motor evoked potentials as outcome measure in progressive multiple sclerosis","author":"Pisa","year":"2020","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.msard.2025.106667_bib0128","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.16278","article-title":"Association of serum neurofilament light levels with long-term brain atrophy in patients with a first multiple sclerosis episode","author":"Plavina","year":"2020","journal-title":"JAMa Netw. Open."},{"key":"10.1016\/j.msard.2025.106667_bib0129","doi-asserted-by":"crossref","DOI":"10.1007\/s00330-020-06738-4","article-title":"2D linear measures of ventricular enlargement may be relevant markers of brain atrophy and long-term disability progression in multiple sclerosis","author":"Pontillo","year":"2020","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.msard.2025.106667_bib0130","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2012-304094","article-title":"Brain atrophy and lesion load predict long term disability in multiple sclerosis","author":"Popescu","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2025.106667_bib0131","article-title":"Age at onset, initial symptomatology and the course of multiple sclerosis","author":"Poser","year":"1982","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.msard.2025.106667_bib0132","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001139","article-title":"Slowly expanding lesions predict 9-year Multiple Sclerosis disease progression","author":"Preziosa","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2025.106667_bib0133","first-page":"1628","article-title":"PRISMS-4: long-term efficacy of interferon-beta-1a in relapsing MS [published correction appears in Neurology 2001 Sep 25;57(6):1146]","volume":"56","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106667_bib0134","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001059","article-title":"Prognostic accuracy of NEDA-3 in long-term outcomes of multiple sclerosis","author":"Prosperini","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2025.106667_bib0135","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001059","article-title":"Prognostic accuracy of NEDA-3 in long-term outcomes of multiple sclerosis","author":"Prosperini","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2025.106667_bib0136","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2010.09.006","article-title":"Spinal cord involvement in multiple sclerosis: a correlative MRI and high-resolution HLA-DRB1 genotyping study","author":"Qiu","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2025.106667_bib0137","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2012-302848","article-title":"Term pregnancies and the clinical characteristics of multiple sclerosis: a population-based study","author":"Ramagopalan","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2025.106667_bib0138","doi-asserted-by":"crossref","DOI":"10.3310\/hta6100","article-title":"A review of the natural history and epidemiology of multiple sclerosis: implications for resource allocation and health economic models","author":"Richards","year":"2002","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.msard.2025.106667_bib0139","doi-asserted-by":"crossref","DOI":"10.1212\/01.wnl.0000238107.31364.21","article-title":"Elevated CSF free kappa light chains correlate with disability prognosis in multiple sclerosis","author":"Rinker","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106667_bib0140","doi-asserted-by":"crossref","DOI":"10.1179\/1743132812Y.0000000088","article-title":"Oligoclonal bands in multiple sclerosis patients: worse prognosis?","author":"Rojas","year":"2012","journal-title":"Neurol. Res."},{"key":"10.1016\/j.msard.2025.106667_bib0141","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/116.1.117","article-title":"Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up","author":"Runmarker","year":"1993","journal-title":"Brain"},{"key":"10.1016\/j.msard.2025.106667_bib0142","doi-asserted-by":"crossref","DOI":"10.1007\/BF00920623","article-title":"Prediction of outcome in multiple sclerosis based on multivariate models","author":"Runmarker","year":"1994","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0144","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000010024","article-title":"Comorbidity is associated with disease activity in MS: findings from the CombiRx trial","author":"Salter","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106667_bib0145","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2013.599","article-title":"Early relapses, onset of progression, and late outcome in multiple sclerosis","author":"Scalfari","year":"2013","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0146","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awq118","article-title":"The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability","author":"Scalfari","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.msard.2025.106667_bib0147","doi-asserted-by":"crossref","DOI":"10.1177\/1352458514525867","article-title":"Combined visual and motor evoked potentials predict multiple sclerosis disability after 20 years","author":"Schlaeger","year":"2014","journal-title":"Mult. Scler."},{"issue":"5","key":"10.1016\/j.msard.2025.106667_bib0148","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/ane.13149","article-title":"Multiple sclerosis relapses contribute to long-term disability","volume":"140","author":"Scott","year":"2019","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.msard.2025.106667_bib0149","doi-asserted-by":"crossref","DOI":"10.1177\/1352458520948212","article-title":"Clinical and MRI characteristics of multiple sclerosis in patients of Middle Eastern and North African ancestry residing in Ontario","author":"Seyman","year":"2021","journal-title":"Canada. Mult. Scler. J."},{"key":"10.1016\/j.msard.2025.106667_bib0150","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000003762","article-title":"Fast multiple sclerosis progression in North Africans","author":"Sidhom","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106667_bib0151","doi-asserted-by":"crossref","DOI":"10.1177\/1352458510386996","article-title":"Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM","author":"Sola","year":"2011","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2025.106667_bib0152","article-title":"Relapse recovery in multiple sclerosis: effect of treatment and contribution to long-term disability","author":"Sotiropoulos","year":"2021","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.msard.2025.106667_bib0153","article-title":"Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study","author":"Stockman","year":"2009","journal-title":"Yearb. Pediatr."},{"key":"10.1016\/j.msard.2025.106667_bib0154","doi-asserted-by":"crossref","DOI":"10.1097\/WNP.0000000000000788","article-title":"Cognitive event-related potentials-the P300 wave is a prognostic factor of long-term disability progression in patients with multiple sclerosis","author":"Szilasiov\u00e1","year":"2022","journal-title":"J. Clin. Neurophysiol."},{"key":"10.1016\/j.msard.2025.106667_bib0155","article-title":"Smoking cessation and the reduction of disability progression in Multiple Sclerosis: a cohort study","author":"Tanasescu","year":"2017","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.msard.2025.106667_bib0156","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-015-7674-y","article-title":"The outcome spectrum of multiple sclerosis: disability, mortality, and a cluster of predictors from onset","author":"Tedeholm","year":"2015","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0157","doi-asserted-by":"crossref","DOI":"10.1159\/000442203","article-title":"Frequency of comorbidities and their association with clinical disability and relapse in multiple sclerosis","author":"Tettey","year":"2016","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.msard.2025.106667_bib0158","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-75290-8","article-title":"The combination of CSF neurofilament light chain and glial fibrillary acidic protein improves the prediction of long-term confirmed disability worsening in multiple sclerosis","author":"Thebault","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2025.106667_bib0159","doi-asserted-by":"crossref","DOI":"10.1007\/s13760-017-0828-1","article-title":"Long-term disability and progression in spinal onset multiple sclerosis","author":"Tiftikcioglu","year":"2018","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.msard.2025.106667_bib0160","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0b013e3181feb26f","article-title":"Brainstem lesions in clinically isolated syndromes","author":"Tintore","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106667_bib0161","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awv105","article-title":"Defining high, medium and low impact prognostic factors for developing multiple sclerosis","author":"Tintore","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.msard.2025.106667_bib0162","doi-asserted-by":"crossref","DOI":"10.1177\/1352458518790397","article-title":"Predicting the profile of increasing disability in multiple sclerosis","author":"Tomassini","year":"2019","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2025.106667_bib0163","doi-asserted-by":"crossref","DOI":"10.1016\/j.ncl.2010.12.008","article-title":"Natural history of multiple sclerosis: have available therapies impacted long-term prognosis?","author":"Trojano","year":"2011","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.msard.2025.106667_bib0164","doi-asserted-by":"crossref","DOI":"10.1002\/ana.21757","article-title":"Real-life impact of early interferon\u03b2 therapy in relapsing multiple sclerosis","author":"Trojano","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0165","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-018-8780-4","article-title":"Smoking at time of CIS increases the risk of clinically definite multiple sclerosis","author":"Van der","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0166","doi-asserted-by":"crossref","DOI":"10.1177\/1352458516679894","article-title":"Hispanic Americans and African Americans with multiple sclerosis have more severe disease course than Caucasian Americans","author":"Ventura","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106667_bib0167","doi-asserted-by":"crossref","DOI":"10.1016\/0303-8467(94)90027-2","article-title":"Pregnancy and multiple sclerosis: the influence on long term disability","author":"Verdru","year":"1994","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.msard.2025.106667_bib0168","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101520","article-title":"Predictors of progression in primary progressive multiple sclerosis in a large Turkish cohort","author":"Vural","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106667_bib0169","doi-asserted-by":"crossref","DOI":"10.1007\/s00330-021-08233-w","article-title":"Association of iron rim lesions with brain and cervical cord volume in relapsing multiple sclerosis","author":"Weber","year":"2022","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.msard.2025.106667_bib0170","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/112.1.133","article-title":"The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability","author":"Weinshenker","year":"1989","journal-title":"Brain"},{"key":"10.1016\/j.msard.2025.106667_bib0171","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.40.9.1354","article-title":"A comparison of sporadic and familial multiple sclerosis","author":"Weinshenker","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106667_bib0172","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/114.2.1057","article-title":"The natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials","author":"Weinshenker","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.msard.2025.106667_bib0173","doi-asserted-by":"crossref","DOI":"10.1177\/1352458511405088","article-title":"Sibling disability risk at onset and during disease progression in familial multiple sclerosis","author":"Wellek","year":"2011","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2025.106667_bib0174","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102801","article-title":"Low vitamin D, but not tobacco use or high BMI, is associated with long-term disability progression in multiple sclerosis","author":"Wesnes","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106667_bib0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2024.123156","article-title":"Comorbid onset of cardiovascular diagnosis and long-term confirmed disability progression in multiple sclerosis: a 15-year follow-up study","author":"Wicks","year":"2024","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2025.106667_bib0176","doi-asserted-by":"crossref","DOI":"10.1080\/01616412.2020.1867947","article-title":"Real world prognosis in MS: does early versus late diagnosis matter?","author":"Zachariah","year":"2021","journal-title":"Neurol. Res."},{"key":"10.1016\/j.msard.2025.106667_bib0177","article-title":"Effects of physical comorbidities on disability progression in multiple sclerosis","author":"Zhang","year":"2018","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2025.106667_bib0178","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.670","article-title":"Variation within MBP gene predicts disease course in multiple sclerosis","author":"Zhou","year":"2017","journal-title":"Brain Behav."},{"key":"10.1016\/j.msard.2025.106667_bib0179","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-016-0623-2","article-title":"Factors associated with benign multiple sclerosis in the New York State MS Consortium (NYSMSC)","author":"Zivadinov","year":"2016","journal-title":"BMC. Neurol."},{"key":"10.1016\/j.msard.2025.106667_bib0180","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000007178","article-title":"Menarche, pregnancies, and breastfeeding do not modify long-term prognosis in multiple sclerosis","author":"Zuluaga","year":"2019","journal-title":"Neurology."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825004092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825004092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T23:16:48Z","timestamp":1774999008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825004092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":175,"alternative-id":["S2211034825004092"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106667","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of long-term outcome in Multiple Sclerosis: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106667","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106667"}}